Publications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (71)

2025

  1. Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study

    International Journal of Antimicrobial Agents, Vol. 66, Núm. 3

  2. Analysis of Clinical Subphenotypes in Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the MRSA-GEIRAS-SEIMC Study

    Open Forum Infectious Diseases, Vol. 12, Núm. 12

  3. Ceftaroline for bloodstream infections caused by methicillin-resistant Staphylococcus aureus: a multicentre retrospective cohort study

    Clinical Microbiology and Infection, Vol. 31, Núm. 5, pp. 793-801

  4. Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools

    Archivos de Bronconeumologia, Vol. 61, Núm. 5, pp. 264-273

  5. Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools

    Archivos de Bronconeumologia, Vol. 61, Núm. 5, pp. 264-273

  6. Criteria for Advanced COPD in Patients Hospitalized Due to COPD Exacerbation: Prevalence and Predictive Capacity

    Archivos de Bronconeumologia

  7. Delphi Consensus on the Management of Patients With Advanced COPD: COPD-Avanz Working Group

    Open Respiratory Archives, Vol. 7, Núm. 2

  8. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry

    Archivos de Bronconeumologia, Vol. 61, Núm. 4, pp. 196-202

  9. Improving End-of-Life Care for COPD Patients: Design and Development of an Intelligent Clinical Decision Support System to Predict One-Year Mortality After Acute Exacerbations

    International Journal of Intelligent Systems, Vol. 2025, Núm. 1

  10. Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis

    Archivos de Bronconeumologia, Vol. 61, Núm. 8, pp. 484-489

  11. Predicting COPD Readmission: An Intelligent Clinical Decision Support System

    Diagnostics, Vol. 15, Núm. 3

  12. Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project

    Healthcare (Switzerland), Vol. 13, Núm. 3

  13. SEPAR and SEEN Consensus Document on Nutritional Assessment and Management in Patients with COPD

    Archivos de Bronconeumologia

  14. The Role of Bronchial Biopsy in the Prediction of Response to Biologic Therapy in Severe Uncontrolled Asthma: A Prospective Study

    Chest, Vol. 167, Núm. 4, pp. 945-955

  15. What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?—data from the RIBRON registry

    Journal of Thoracic Disease, Vol. 17, Núm. 10, pp. 9003-9012

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  2. Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery

    Open Respiratory Archives, Vol. 6, Núm. 3

  3. Long COVID: epidemiology and clinical impact

    ERS Monograph, Vol. 2024, Núm. 105, pp. 227-239

  4. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study

    ERJ Open Research, Vol. 10, Núm. 1

  5. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology